Paricalcitol is a seco-cholestane and a hydroxy seco-steroid. Among its listed roles, it functions as a antiparathyroid drug. Functionally, it is related to vitamin D2. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Zemplar and Paracalcin. Its PubChem CID is 5281104.
Paricalcitol
| CAS No | 131918-61-1 |
|---|---|
| Molecular Formula | C27H44O3 |
| Molecular Weight | 416.6 g/mol |
| Synonyms | (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Paricalcitol is a seco-cholestane and a hydroxy seco-steroid. Among its listed roles, it functions as a antiparathyroid drug. Functionally, it is related to vitamin D2.
The listed CAS number is 131918-61-1.
The listed molecular formula is C27H44O3.
The listed molecular weight is 416.6 g/mol.
(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol.
The source lists Zemplar and Paracalcin.